EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Strategic Partners A/S does not have significant operations (STRAP) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Strategic Partners A/S does not have significant operations DKK 305, price DKK 640, upside -52.4%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · DK · ISIN DK0062502894

SP Thin data Sep 23, 2026

Strategic Partners A/S does not have significant operations

STRAP · CO

Weakest SetupStrongly overvalued and low quality.

!Fair value kr 304.59 · Strongly overvalued (−52%)
!Quality 40/100
!Weak Growth
!negative free cash flow
✓Ranks above peers (5/7)
!Narrow moat 3/100
!Insider activity 40/100
!Evidence only low, so the estimate is less certain
Watch Strategic Partners A/S does not have significant operations for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 100,000 kr 530.00 Fair Value kr 304.59 Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range kr 530.00 – kr 100,000 · fair‑value band kr 201.03 – kr 380.73 · the kr 640.00 price screens above the kr 304.59 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Strategic Partners A/S does not have significant operations in your weekly email

Every Wednesday you see whether Strategic Partners A/S does not have significant operations is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.

Stock analysis

Strategic Partners A/S does not have significant operations (STRAP) currently trades at kr 640.00, while our model-based Fair Value estimate is kr 304.59, implying the stock looks roughly 110.1% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: kr 201.03 (bear) to kr 380.73 (bull), the price of kr 640.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Strategic Partners A/S does not have significant operations reported revenue of 309K DKK in FY2025 versus 0 DKK in FY2020. Reported net income was −859K DKK in FY2025.

Key figures

Market cap 26.7M DKK (≈ $4.1M) · P/S ratio 70.9 · EPS (TTM) kr −20.99 · Net margin −278% · Return on equity −4.6% · Return on assets (EBIT) −54.8% · Operating margin −309% · Revenue (TTM) 309K DKK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades about 32% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −52%, STRAP screens richer than that median.

Fair Value models

Bear kr 201.03 Fair Value kr 304.59 Bull kr 380.73
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) kr 222.38 kr 297.98 kr 444.75 51
All 1 models by family
Asset-Based
NCAV (Graham) kr 222.38 kr 297.98 kr 444.75 51

Open the full fair value analysis →

Notify me when STRAP reaches fair value

Put STRAP on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 40/100

Of which business quality 44 · Market factors (momentum, volatility) 32

Profitability 1
Margins and returns on capital today
Quality Growth 38
Are margins and returns improving?
Cashflow 50
Earnings quality: real cash, not paper profit
Fin. Strength 77
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 34
Price trend over the last 3–12 months (market factor)
52W Momentum 9
Distance to the 52-week high (market factor)
Net Issuance 11
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

STRAP screens 110% overvalued. Compare with Vertex Pharmaceuticals Incorporated →

Compare Strategic Partners A/S does not have significant operations with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 651 stocks

Beats the industry median on 4/6 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 44 · Above median
Fair Value upside −52% · Below median
Profitability
Return on assets −7% · Above median
Growth and dividend
Revenue growth 0% · Above median

Valuation Multiplesvs Biotechnology median · lower = cheaper

P/B 0.22× · Cheapest 25%
P/S (TTM) 13.17× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Biotechnology stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Vertex Pharmaceuticals Incorporated VRTX $514.99 $566.49 +10%
Regeneron Pharmaceuticals, Inc REGN $803.90 $1,252 +56%
argenx SE ARGX $963.79 $918.60 −5%
Samsung Biologics Co 207940 1,366,000 KRW 1,502,600 KRW +10%
CSL Limited CSL A$179.24 A$197.16 +10%
Alnylam Pharmaceuticals, Inc ALNY $251.65 $218.36 −13%
Royalty Pharma plc RPRX $58.52 $24.22 −59%
BeOne Medicines AG 6160 HK$218.20 HK$169.72 −22%
Celltrion, Inc 068270 177,400 KRW 74,519 KRW −58%
BioNTech SE BNTX $100.87 $63.62 −37%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Strategic Partners A/S does not have significant operations Fair Value". https://www.fairvalue-calculator.com/stock/STRAP

Frequently asked questions

Is Strategic Partners A/S does not have significant operations (STRAP) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of kr 304.59 versus a price of kr 640.00, about −52% upside (overvalued).
What is the fair value of STRAP?
Our model-based fair value for Strategic Partners A/S does not have significant operations is kr 304.59 (as of Sep 23, 2026), built from audited fundamentals. The current price: kr 640.00.
What is the quality score of STRAP?
Strategic Partners A/S does not have significant operations has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Strategic Partners A/S does not have significant operations (STRAP)?
Our model-based price target is the fair value of kr 304.59 (as of Sep 23, 2026) from 1 valuation models. Cautious scenario kr 201.03, optimistic scenario kr 380.73. It is a calculation from audited fundamentals, not an analyst target.
What is the Strategic Partners A/S does not have significant operations stock forecast for 2026?
Our models put fair value at kr 304.59, about −52% upside versus a price of kr 640.00 (overvalued). Cautious scenario kr 201.03, optimistic scenario kr 380.73. The calculation is refreshed regularly with new filings.
What is the revenue of Strategic Partners A/S does not have significant operations (STRAP)?
Strategic Partners A/S does not have significant operations reported trailing-twelve-month revenue of about 309K DKK (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Strategic Partners A/S does not have significant operations (STRAP)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Strategic Partners A/S does not have significant operations it is kr 304.59 per share (as of Sep 23, 2026), against a price of kr 640.00. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Strategic Partners A/S does not have significant operations stock overvalued or undervalued in 2026?
As of Sep 23, 2026, STRAP trades above its calculated fair value: price kr 640.00, fair value kr 304.59, a gap of about −52% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of STRAP?
No. The price is what the market pays today (kr 640.00); the fair value is what the company's own numbers justify (kr 304.59). For Strategic Partners A/S does not have significant operations the two are kr 335.41 per share apart. That gap is exactly why we show both numbers side by side.
How much is Strategic Partners A/S does not have significant operations worth?
The market values Strategic Partners A/S does not have significant operations at about 26.7M DKK (market capitalisation, as of Sep 23, 2026). Per share that is kr 640.00; our models calculate a fair value of kr 304.59 per share.
What do the bullish and bearish scenarios say about STRAP?
Our models span a range for Strategic Partners A/S does not have significant operations: cautious scenario kr 201.03, base kr 304.59, optimistic kr 380.73 per share (as of Sep 23, 2026, price kr 640.00). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Strategic Partners A/S does not have significant operations (STRAP)?
Balance-sheet figures for Strategic Partners A/S does not have significant operations (as of Sep 23, 2026): return on equity −4.6%. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is STRAP from its 52-week high?
Strategic Partners A/S does not have significant operations trades at kr 640.00, about 32% below its 52-week high of kr 946.00 and 21% above the low of kr 530.00 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of kr 304.59 is for.
Which stocks are comparable to Strategic Partners A/S does not have significant operations?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, argenx SE, Samsung Biologics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Strategic Partners A/S does not have significant operations stock attractive at the current price?
The data as of Sep 23, 2026: price kr 640.00, calculated fair value kr 304.59 (−52%), Quality Score 40/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of STRAP calculated?
We run Strategic Partners A/S does not have significant operations through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 304.59, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Strategic Partners A/S does not have significant operations itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Strategic Partners A/S does not have significant operations (STRAP)?
The closing price on Sep 23, 2026 was kr 640.00. Our model-based fair value is kr 304.59, about −52% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Strategic Partners A/S does not have significant operations right now?
The price sits above even our optimistic bull case (kr 380.73). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (kr 201.03 to kr 380.73) leaves room in how you read the outcome.

Key figures of Strategic Partners A/S does not have significant operations

How large is the market capitalisation of Strategic Partners A/S does not have significant operations (STRAP)?
The market capitalisation of Strategic Partners A/S does not have significant operations is 26.7M DKK (≈ $4.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Strategic Partners A/S does not have significant operations (STRAP)?
The price-to-sales ratio of Strategic Partners A/S does not have significant operations is 70.9 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Strategic Partners A/S does not have significant operations (STRAP)?
Earnings per share at Strategic Partners A/S does not have significant operations are kr −20.99. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Strategic Partners A/S does not have significant operations (STRAP)?
The net margin of Strategic Partners A/S does not have significant operations is −278% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Strategic Partners A/S does not have significant operations (STRAP)?
The return on equity (ROE) of Strategic Partners A/S does not have significant operations is −4.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Strategic Partners A/S does not have significant operations (STRAP)?
On an EBIT basis the return on assets of Strategic Partners A/S does not have significant operations is −54.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Strategic Partners A/S does not have significant operations (STRAP)?
The operating margin of Strategic Partners A/S does not have significant operations is −309% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does Strategic Partners A/S does not have significant operations (STRAP) generate?
The free cash flow of Strategic Partners A/S does not have significant operations is −2.1M DKK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Strategic Partners A/S does not have significant operations (STRAP) hold?
Strategic Partners A/S does not have significant operations holds more cash than debt, 394K DKK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Strategic Partners A/S does not have significant operations in the live analysis

One click puts Strategic Partners A/S does not have significant operations on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.